The results show that tumor outgrowth was significantly reduced in the Cd38‒/‒ mice compared to WT mice and that at 26 days post-injection the average tumor volume in Cd38‒/‒ mice was significantly smaller than in WT mice (Figure 1A). This evidence concerns the gene CD38 and neoplasm.